COVID-19
At the beginning of the COVID-19 pandemic, depression, and anxiety levels increased by a staggering 25% worldwide. Multiple stressors influenced this, including loneliness, financial concerns, death of loved ones, and burnout in healthcare workers, among other factors. Women were among the most severely affected by the pandemic. Women with risky alcohol use during the pandemic were also found to have higher anxiety and depression compared to those with low-risk use. Women are becoming increasingly likely to use substances, as shown by the increasing alcohol sales and opioid overdoses during the ongoing pandemic.
The infectious respiratory disease Coronavirus 2019, or COVID-19, continues to be studied (and spread), and new information and updates about long-term effects are being released. COVID-19 data regarding cases, deaths, and current vaccinations are released weekly on MDH’s website. For comprehensive information on the impacts of COVID-19 on rural MN, look to the Center for Rural Policy’s Report, which explores the data, access to health care, and impacts on the economy and workforce.

Source: WHO, MDH

Source: WHO, MDH
COVID-19 Vaccines
As of August 2023, 6,554,026 total COVID-19 vaccine doses had been administered to MN women, and 29.6% of MN women were up to date on COVID-19 vaccinations, compared to 18.4% of MN residents
MN Race and Ethnicity COVID-19 Data (per 100,000 people)
This scaling allows for the outcome of cases or deaths from COVID-19 to be compared to the size of each population group.

Source: MDH

Source: MDH
Mpox
Mpox cases did not occur in the U.S. until May 2022. Symptoms often include a blister-like rash that can appear on various areas of the body.
In MN as of December 2024,
- 274 cases of Mpox have been identified
- 3% of cases are women
- 10 cases have been hospitalized, and there has been 1 death associated with Mpox

Source: MDH
More information about Mpox can be found on the MDH website.